MedPath

The Effects Assessment of the Polygonatum Kingianum Extract on Endurance Performance and Anti-fatigue

Not Applicable
Completed
Conditions
Fatigue
Interventions
Dietary Supplement: Placebo drink
Dietary Supplement: Polygonatum kingianum extract drink
Registration Number
NCT05877677
Lead Sponsor
TCI Co., Ltd.
Brief Summary

To assess the efficacy of polygonatum kingianum extract on endurance performance and anti-fatigue

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
50
Inclusion Criteria
  • Healthy male aged 30-60 years old
  • Must read and sign the informed consent form
  • During the experiment, do not change the lifestyle and eating habits
  • Cooperate not to engage in high-intensity exercise 48 hours before each experiment
Exclusion Criteria
  • Subject who is not willing to participate in this study.
  • People with serious diseases of heart, liver, kidney, endocrine and other organs (such as hypertension, diabetes, renal dysfunction and heart-related diseases) and mental patients
  • People who have undergone surgery within 6 months or have lower limb injuries
  • People who are allergic to Polygonatum kingianum extract
  • Participate in other clinical trials related to anti-fatigue within four weeks of the trial
  • Students who are currently taking courses taught by the principal investigator of this trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo drinkPlacebo drinkconsume 1 bottle per day
Polygonatum kingianum extract drinkPolygonatum kingianum extract drinkconsume 1 bottle per day
Primary Outcome Measures
NameTimeMethod
The change of blood PDE5 gene expressionDay 0, day 14, day28

Fasting venous blood was sampled to measure the expression of PDE5 gene

The change of aerobic enduranceDay 0, day 14, day28

3-min step test is used to assess aerobic endurance

The change of continuous attention performanceDay 0, day 14, day28

Canon continuous attention software (Conners' Continuous Performance Test) is used to assess continuous attention performance

The change of concentration of testosterone in bloodDay 0, day 14, day28

Fasting venous blood was sampled to measure concentrations of testosterone

Secondary Outcome Measures
NameTimeMethod
The change of blood nitric oxide (NO)Day 0, day 14, day28

Fasting venous blood was sampled to measure concentrations of nitric oxide

The change of self-assessment fatigue conditionDay 0, day 14, day28

A 10 point likert scale was utilized to evaluate fatigue condition. The higher the score, the higher the fatigue level.

Trial Locations

Locations (1)

National Pingtung University of Science and Technology

🇨🇳

Pingtung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath